SVB UK’s Rescue Good News For Europe’s Fragile Biotech Sector
Biotech Money Is Safe, But Episode Undermines Confidence
The British government helped secure HSBC as a buyer for SVB UK, but sector leaders want to see more support in the shape of sustained R&D tax relief.
You may also be interested in...
Silicon Valley Bank’s Failure Rattles Investors In Biopharma Sector
Investment bank analysts, VC funds and biopharma companies all sought to calm investors’ nerves as a go-to financial institution for tech and biotech collapsed.
Redx Joins Forces With Jounce To Form $425m Cancer And Fibrosis Company
After a rollercoaster of a journey to date, UK firm Redx unveiled plans to merge with US biotech Jounce in a deal that would create a $425m transatlantic company with a robust cash runway through to 2025.
The ChatGPT Revolution Comes To Pharma Business, Starting With Medical Congresses
ChatGPT’s ability to perform sophisticated analysis and writing tasks has taken the world by storm, and now one developer has launched its own AI aimed at revolutionizing pharma’s business intelligence functions.